María Inés
Gómez Otero
![Foto de María Inés](/img/nophoto.png)
![Foto de Instituto de Salud Carlos III](/img/noimage_org.png)
Instituto de Salud Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (9)
2024
-
Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis
Medicina Clinica, Vol. 162, Núm. 7, pp. e1-e7
-
Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction
Clinical Research in Cardiology, Vol. 113, Núm. 8, pp. 1171-1182
-
Prognostic value of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in cardiac amyloidosis
Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 634-644
2023
-
Heart failure risk scores in advanced heart failure patients: insights from the LEVO-D registry
ESC Heart Failure, Vol. 10, Núm. 5, pp. 2875-2881
2022
-
Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy
Mayo Clinic Proceedings, Vol. 97, Núm. 2, pp. 261-273
-
Cardiac amyloidosis: Description of a series of 143 cases
Medicina Clinica, Vol. 159, Núm. 5, pp. 207-213
-
Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life
ESC Heart Failure, Vol. 9, Núm. 5, pp. 3071-3078
-
Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes
Postgraduate Medicine, Vol. 134, Núm. 4, pp. 420-428
2021
-
Sex and Heart Failure Treatment Prescription and Adherence
Frontiers in Cardiovascular Medicine, Vol. 8